6505--Simvastatin Tablets (VA-26-00009813)
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), specifically the NAC PHARMACEUTICALS (36E797) office, has awarded a contract for Simvastatin Tablets to GOLDEN STATE MEDICAL SUPPLY, INC. The award, identified as 36E79726D0023, is valued at $16,792,934.72 and was made on March 10, 2026.
Scope of Work
This award stems from Solicitation Number 36E79725R0066, which sought a supply source for Simvastatin tablets in various strengths (5mg, 10mg, 20mg, 40mg, 80mg) and package sizes. The contract supports the VA and Department of Defense (DoD) Pharmaceutical Prime Vendor (PPV) Programs, aiming to ensure nationwide product availability and consistency with volume-based, committed-use pricing.
Contract Details
- Awardee: GOLDEN STATE MEDICAL SUPPLY, INC. (UEI: GQLDJJ8AQNN5)
- Award Number: 36E79726D0023
- Award Amount: $16,792,934.72
- Award Date: March 10, 2026
- Contract Type: Firm Fixed Price, Indefinite-Delivery Requirements contract (based on original solicitation).
- Set-Aside: Unrestricted (based on original solicitation).
- Product Service Code: 6505 (Drugs And Biologicals)
- NAICS Code: 325412 (Pharmaceutical and Medicine Manufacturing)
Evaluation
The original solicitation (36E79725R0066) indicated that offers were evaluated on a Lowest Price Technically Acceptable (LPTA) basis. Technical acceptability required FDA approval, compliance with FDA cGMP standards, unique 11-digit NDCs, and bar code labeling compliance.
Additional Notes
This award notice signifies the completion of the procurement process for Simvastatin Tablets, providing essential pharmaceuticals through the PPV Programs.